Alexion issues stock for $4.31 million 1.375% convertibles held by CCS

By Jennifer Chiou

New York, April 17 - Alexion Pharmaceuticals, Inc. issued 278,771 of its shares in exchange for $4.31 million of its 1.375% convertible senior notes due 2012 beneficially owned by CCS, LLC, according to an 8-K filing with the Securities and Exchange Commission.

After the exchange, the outstanding principal balance of the notes is $46.18 million.

The company said it may offer additional exchanges as opportunities arise.

Alexion is a Cheshire, Conn.-based biotechnology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.